The Effect of miR-361-3p Targeting TRAF6 on Apoptosis of Multiple Myeloma Cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
microRNA-361-3p (miR-361-3p) is involved in the carcinogenesis of oral cancer and pancreatic catheter adenocarcinoma, and has anti-carcinogenic effects on non-small cell lung cancer (NSCLC). However, its effect on multiple myeloma (MM) is less reported. Here, we found that upregulating the expression of miR-361-3p inhibited MM cell viability and promoted MM apoptosis. We measured expressions of tumor necrosis factor receptor-associated factor 6 (TRAF6) and miR-361-3p in MM cells and detected the viability, colony formation rate, and apoptosis of MM cells. In addition, we measured expressions of apoptosis-related genes Bcl-2, Bax, and Cleaved caspase-3 (C caspase-3). The binding site between miR-361-3p and TRAF6 was predicted by TargetScan. Our results showed that miR-361-3p was low expressed in the plasma of MM patients and cell lines, while its overexpression inhibited viability and colony formation of MM cells and increased the cell apoptosis. Furthermore, TRAF6, which was predicted to be a target gene of miR-361-3p, was highexpressed in the plasma of patients and cell lines with MM. Rescue experiments demonstrated that the effect of TRAF6 on MM cells was opposite to that of miR-361-3p. Upregulation of miR-361-3p induced apoptosis and inhibited the proliferation of MM cells through targeting TRAF6, suggesting that miR-361-3p might be a potential target for MM therapy.
Abstract
microRNA-361-3p (miR-361-3p) is involved in the carcinogenesis of oral cancer and pancreatic catheter adenocarcinoma, and has anti-carcinogenic effects on non-small cell lung cancer (NSCLC). However, its effect on multiple myeloma (MM) is less reported. Here, we found that upregulating the expression of miR-361-3p inhibited MM cell viability and promoted MM apoptosis. We measured expressions of tumor necrosis factor receptor-associated factor 6 (TRAF6) and miR-361-3p in MM cells and detected the viability, colony formation rate, and apoptosis of MM cells. In addition, we measured expressions of apoptosis-related genes Bcl-2, Bax, and Cleaved caspase-3 (C caspase-3). The binding site between miR-361-3p and TRAF6 was predicted by TargetScan. Our results showed that miR-361-3p was low expressed in the plasma of MM patients and cell lines, while its overexpression inhibited viability and colony formation of MM cells and increased the cell apoptosis. Furthermore, TRAF6, which was predicted to be a target gene of miR-361-3p, was highexpressed in the plasma of patients and cell lines with MM. Rescue experiments demonstrated that the effect of TRAF6 on MM cells was opposite to that of miR-361-3p. Upregulation of miR-361-3p induced apoptosis and inhibited the proliferation of MM cells through targeting TRAF6, suggesting that miR-361-3p might be a potential target for MM therapy.
참고문헌 (34)
- Adams JM, "The BCL-2 arbiters of apoptosis and their growing role as cancer targets", Cell Death Differ, 25, pp.27~36 (2018)
- Amodio N, "Epigenetic modifications in multiple myeloma : recent advances on the role of DNA and histone methylation", Expert Opin. Ther. Targets, 21, pp.91~101 (2017)
- Amodio N, "Therapeutic targeting of miR-29b", HDAC4epigenetic loop in multiple myeloma, 2016, pp.15, 1364~1375
- Ivyna Pau Ni Bong, "MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy", Genes & Genomics, 39(5), pp.533~540 (2017), 한국유전학회[DOI]
- Botta C, "MiR-29b antagonizes the pro-inflammatory tumorpromoting activity of multiple myeloma-educated dendritic cells", Leukemia, 32, pp.1003~1015 (2018)
- Buschhaus J, "A Caspase-3 reporter for fluorescence lifetime imaging of single-cell apoptosis", Cells, 7, pp.57~ (2018)
- Chen W, "MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC", J. Exp. Clin. Cancer Res, 35, pp.76~ (2016)
- Fang J, "Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia", Nat. Immunol, 18, pp.236~245 (2017)
- Fang J, "TRAF6 mediates basal activation of NF-κB necessary for hematopoietic stem cell homeostasis", Cell Rep, 22, pp.1250~1262 (2018)
- Gu Y, "LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression", Oncotarget, 8, pp.101984~101993 (2017)
- Hu J, "MiR-361-3p regulates ERK1", 2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma, 2018, pp.9, 807~
- Hu Q, "miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6", Oncol. Rep, 39, pp.3015~3024 (2018)
- Karakas LA, "Analysis of Bcl-2, PTEN, p53, and Ki-67 expressions in endometrial cancer arising from endometrial polyp", Eur. J. Gynaecol. Oncol, 40, pp.796~802 (2019)
- Karpel-Massler G, "Inhibition of mitochondrial matrix chaperones and antiapoptotic Bcl-2 family proteins empower antitumor therapeutic responses", Cancer Res, 77, pp.3513~3526 (2017)
- Khodadadi-Jamayran A, "Prognostic role of elevated mir24-3p in breast cancer and its association with the metastatic process", Oncotarget, 9, pp.12868~12878 (2018)
- Kumar SK, "Multiple myeloma, version 3.2017, NCCN clinical practice guidelines in oncology", J. Natl. Compr. Canc. Netw, 15, pp.230~269 (2017)
- Lazzari E, "Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma", Nat. Commun, 8, pp.1922~ (2017)
- Ling H, "The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis", Gut, 65, pp.977~989 (2016)
- Lulla AR, "miR-6883 family miRNAs target CDK4", 6 to induce G1phase cell-cycle arrest in colon cancer cells, 2017, pp.77, 6902~6913
- Manier S, "Genomic complexity of multiple myeloma and its clinical implications", Nat. Rev. Clin. Oncol, 14, pp.100~113 (2017)
- Meng YB, "Long moncoding RNA CRNDE promotes multiple myeloma cell growth by suppressing miR-451", Oncol. Res, 25, pp.1207~1214 (2017)
- Moreau P, "Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up", Ann. Oncol, 28(suppl 4), pp.iv52~iv61 (2017)
- Morgan JJ, "TRAF6 Silencing attenuates multiple myeloma cell adhesion to bone marrow stromal cells", Int. J. Mol. Sci, 20, pp.702~ (2019)
- Rastgoo N, "Role of epigenetics-microRNA axis in drug resistance of multiple myeloma", J. Hematol. Oncol, 10, pp.121~ (2017)
- Shen X, "Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum", Cancer Biomark, 18, pp.257~263 (2017)
- Tang L, "Regulation of nonylphenol-induced reproductive toxicity in mouse spermatogonia cells by miR-361-3p", Mol. Rep. Dev, 84, pp.1257~1270 (2017)
- Tassone P, "Inhibitors of mir-17-92 cluster for anti-tumor activity in multiple myeloma and other malignancies", Google Patents, ~ (2018)
- Tian L, "MiR-361-5p inhibits the mobility of gastric cancer cells through suppressing epithelialmesenchymal transition via the Wnt", beta-catenin pathway, 2018, pp.675, 102~109
- Xia Y, "Pterostilbene attenuates acute kidney injury in septic mice", Exp. Ther. Med, 15, pp.3551~3555 (2018)
- Xu Z, "MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway", Oncol. Rep, 37, pp.1261~1269 (2017)
- Yonemori M, "Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer", Cancer Sci, 107, pp.1233~1242 (2016)
- Zhao D, "MicroRNA-361-3p regulates retinoblastoma cell proliferation and stemness by targeting hedgehog signaling", Exp. Ther. Med, 17, pp.1154~1162 (2019)
- Zhao Y, "Plant and Animal microRNAs(miRNAs)and their potential for inter-kingdom communication", Cell Mol. Neurobiol, 38, pp.133~140 (2018)
- Zhao Y, "MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting cMet", Am. J. Transl. Res, 9, pp.2437~2446 (2017)